Back to Search
JOHN GRAFF, DO
DO
Anatomic Pathology & Clinical Pathology Physician
NPI: 1477990125IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
20A13264(CA)
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
20A13264(CA)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 2012
Research & Publications (20)
Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism.
PMID 19180189·PLoS Pathog·2009
7-preclinical
Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
PMID 18245460·Cancer Res·2008
6-review
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.
PMID 18156609·J Antimicrob Chemother·2008
4-observational
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
PMID 17916229·J Thromb Haemost·2007
2-rct
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
PMID 17873238·J Clin Pharmacol·2007
2-rct
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study.
PMID 17577465·Clin Ther·2007
3-trial
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.
PMID 17474542·Int J Clin Pharmacol Ther·2007
4-observational
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.
PMID 17382720·J Urol·2007
3-trial
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
PMID 16321613·Clin Pharmacol Ther·2005
3-trial
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents.
PMID 16149028·Semin Thromb Hemost·2005
8-other
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
PMID 15183041·Thromb Res·2004
4-observational
Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans.
PMID 12919181·Br J Clin Pharmacol·2003
3-trial
Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs.
PMID 12741684·Clin Exp Metastasis·2003
6-review
Disassociation of carbon disulfide-induced depression of flash-evoked potential peak N166 amplitude and norepinephrine levels.
PMID 12700426·Toxicol Sci·2003
7-preclinical
Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
PMID 12386643·Clin Pharmacol Ther·2002
4-observational
Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma.
PMID 11901476·Expert Opin Ther Targets·2002
6-review
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.
PMID 11861803·J Pharmacol Exp Ther·2002
8-other
Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
PMID 11751475·Clin Cancer Res·2001
4-observational
Integrin-linked kinase expression increases with prostate tumor grade.
PMID 11448915·Clin Cancer Res·2001
8-other
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab.
PMID 11422017·Br J Clin Pharmacol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4400 V ST STE 1107, DEPARTMENT OF PATHOLOGY
SACRAMENTO, CA 95817 - Phone
- (916) 734-0299
Quick Facts
- NPI
- 1477990125
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile